Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introduction to the special section.

Michael Maes1

  • 1Department of Psychiatry, University Hospital of Maastricht, The Netherlands. crc.mh@skynet.be

The International Journal of Neuropsychopharmacology
|December 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates.

Metabolic brain disease·2020
Same author

How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia.

Brain sciences·2020
Same author

Impairments in Peripheral Blood T Effector and T Regulatory Lymphocytes in Bipolar Disorder Are Associated with Staging of Illness and Anti-cytomegalovirus IgG Levels.

Molecular neurobiology·2020
Same author

Teaching hip surgery to orthopaedic residents: what's new?

Hip international : the journal of clinical and experimental research on hip pathology and therapy·2020
Same author

CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders.

Pharmaceuticals (Basel, Switzerland)·2020
Same author

The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6.

Diagnostics (Basel, Switzerland)·2020
Same journal

Ketamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder.

The international journal of neuropsychopharmacology·2026
Same journal

Genetic overlap between treatment-resistant schizophrenia and smoking initiation.

The international journal of neuropsychopharmacology·2026
Same journal

External Validation as the Critical Step for Predictive Biomarkers.

The international journal of neuropsychopharmacology·2026
Same journal

Viloxazine occupies the 5-HT2C receptor in the macaca fascicularis brain in vivo: A [11C]CIMBI-36 positron emission tomography study.

The international journal of neuropsychopharmacology·2026
Same journal

Divergent effects of interleukin-6 and ghrelin on remission and relapse in depression treatment.

The international journal of neuropsychopharmacology·2026
Same journal

Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program.

The international journal of neuropsychopharmacology·2026
See all related articles

The inflammatory response system (IRS) may play a role in causing depression. Research suggests that increased pro-inflammatory cytokines are linked to depression, and antidepressants may suppress their production.

Area of Science:

  • Neuropsychopharmacology
  • Immunopsychiatry
  • Depression Pathophysiology

Background:

  • The relationship between the inflammatory response system (IRS) and major depression requires further investigation.
  • Existing research explores the hypothesis that IRS activation contributes to the development of endogenous and organic depression.

Purpose of the Study:

  • To review the current evidence linking IRS activation to the pathophysiology and etiology of major depressive disorders.
  • To assess the conditions necessary to support the hypothesis of IRS involvement in depression.

Main Methods:

  • Systematic review of studies published over the last 11 years.
  • Analysis of the role of pro-inflammatory cytokines (e.g., IL-1beta, IL-6, TNF-alpha, IFN-gamma) in depression.

Related Experiment Videos

Main Results:

  • Evidence suggests IRS activation, including increased pro-inflammatory cytokine production, is associated with depression.
  • Pro-inflammatory cytokines affect stress-sensitive brain systems like the serotonergic system and the hypothalamic-pituitary-adrenal (HPA) axis.
  • Antidepressants may suppress the production of these cytokines.

Conclusions:

  • The hypothesis that IRS activation is implicated in the pathophysiology of certain depression types is supported by current findings.
  • Future research should investigate the efficacy of anti-inflammatory drugs in depression treatment and the role of genetic variants in IRS susceptibility to depression.